A Low body fat mass ratio predicts poor prognosis in patients with advanced non-small cell lung cancer

dc.authorid0000-0002-7931-2941en_US
dc.authorid0000-0003-0882-0524en_US
dc.authorid0000-0003-3878-988Xen_US
dc.authorid0000-0001-7336-871Xen_US
dc.authorid0000-0002-7451-2786en_US
dc.authorid0000-0003-0396-7498en_US
dc.contributor.authorOruç, Zeynep
dc.contributor.authorAkbay, Ahmet
dc.contributor.authorKaplan, M. Ali
dc.contributor.authorOruç, İdris
dc.contributor.authorUrakçı, Zuhat
dc.contributor.authorKüçüköner, Mehmet
dc.contributor.authorIşıkdoğan, Abdurrahman
dc.date.accessioned2023-04-07T11:16:19Z
dc.date.available2023-04-07T11:16:19Z
dc.date.issued2022en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Onkoloji Ana Bilim Dalıen_US
dc.description.abstractPurpose The aim of this study was to investigate the effect of the body fat mass ratio on survival and prognosis in advanced non-small-cell lung cancer patients. Methods The study includes 200 patients who were diagnosed with advanced non-small-cell lung cancer between 2014 and 2018 and whose body fat mass percentage and body mass index (BMI) were determined using the Tanita Body Composition Analyzer during admission. Results All patients had advanced incurable non-small-cell lung cancer (30% had locally advanced disease, 70% were stage IV). In the univariate and multivariate analyses, age, gender, histopathological type, smoking history, comorbidities, weight loss in the last six months and body mass index had no statistically significant effect on survival (p > 0.05). However, the performance status (p = 0.008), metastatic status (p = 0.003) and body fat mass ratio (p = 0.01) were found to have a significant effect on overall survival (OS): the median OS was 16.4 mo, in patients with the BFM ratio <= 22% and 29.2 mo, in those with > 22% (p = 0.01). Conclusion In this study, it was found that the body fat mass ratio was an important prognostic factor in patients with advanced non-small-cell lung cancer.en_US
dc.identifier.citationOruç, Z., Akbay, A., Kaplan, M.A., Oruç, İ., Urakçı, Z., Küçüköner, M. ve diğerleri (2022). A Low body fat mass ratio predicts poor prognosis in patients with advanced non-small cell lung cancer. Nutrition and Cancer-International Journal, 74(9), 3284-3291.en_US
dc.identifier.doi10.1080/01635581.2022.2074064
dc.identifier.endpage3291en_US
dc.identifier.issn0163-5581
dc.identifier.issn1532-7914
dc.identifier.issue9en_US
dc.identifier.pmid35543082
dc.identifier.scopus2-s2.0-85130238981
dc.identifier.scopusqualityQ1
dc.identifier.startpage3284en_US
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/01635581.2022.2074064
dc.identifier.urihttps://hdl.handle.net/11468/11642
dc.identifier.volume74en_US
dc.identifier.wosWOS:000793897100001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorOruç, Zeynep
dc.institutionauthorAkbay, Ahmet
dc.institutionauthorKaplan, Muhammet Ali
dc.institutionauthorUrakçı, Zuhat
dc.institutionauthorKüçüköner, Mehmet
dc.institutionauthorIşıkdoğan, Abdurrahman
dc.language.isoenen_US
dc.publisherRoutledge Journals Taylor & Francis Ltd.en_US
dc.relation.ispartofNutrition and Cancer-International Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleA Low body fat mass ratio predicts poor prognosis in patients with advanced non-small cell lung canceren_US
dc.titleA Low body fat mass ratio predicts poor prognosis in patients with advanced non-small cell lung cancer
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
A Low Body Fat Mass Ratio Predicts Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer.pdf
Boyut:
775.74 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: